arrow_back Trending Legislation
Share share

Expanding Fight Against Counterfeit Drugs and Illicit Trafficking.

This Act expands the scope of existing sanctions legislation from focusing solely on fentanyl and opioids to include all illicit drugs, counterfeit pharmaceuticals, and "copy-cat ingredients." The goal is to enhance public health and safety by targeting foreign traffickers who introduce dangerous, substandard imitation substances into the market. It also streamlines intelligence operations related to drug trafficking.
Key points
The government's power to impose sanctions now targets foreign traffickers of all illicit drugs, counterfeit drugs, and imitation ingredients, moving beyond the previous focus on opioids.
New definitions are introduced to specifically combat "copy-cat ingredients"—substances mimicking approved prescription drugs but failing quality standards—aiming to protect consumers from dangerous fakes.
Waivers allowing access to prescription medications despite sanctions are now strictly limited to drugs officially listed as being in short supply by the Secretary of Health and Human Services.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Combating Counterfeit Pharmaceuticals Act of 2025
Print number: S 3134
Sponsor: Sen. Cotton, Tom [R-AR]
Process start date: 2025-11-06